I’ve been dealing with back pain off and on for more than a decade. I’ve seen doctors, had X-rays — you name it, I’ve done it. The diagnosis: Bad posture. As a writer, I spend long hours hunched over ...

The Center for Myokine Convergence Research at Korea University College of Medicine (Director: Professor Hyeon Soo Kim, Department of Anatomy, Korea University College of Medicine) has signed a ...

Spinal injected into spine by anesthesiologist before total knee replacement surgery Trump now has three options. They are all bad Watermelon sales crash as family of four die after eating the fruit ...

A hormone traditionally used to treat bone loss may hold the key to stopping chronic back pain at its source, according to a new study. Chronic back pain is often linked to the deterioration of spinal ...

When a two-year-old boy suffered a catastrophic injury that severed the connection between his skull and spine, doctors across Europe told his family there was no hope. His spinal cord was completely ...

CHICAGO, Feb. 3, 2026 /PRNewswire/ -- For individuals struggling to find relief from chronic joint and muscle pain, Synergy Spine & Performance is now featuring Emsculpt NEO, an advanced, non-invasive ...

Dr. John Watkins from Centennial Spine and Pain joins New Mexico Living to talk about Complex Regional Pain Syndrome. He speaks on what it is and how it can be remedied. Dr. Watkins says it is a ...

HONOLULU (HawaiiNewsNow) - Back pain will affect nearly half of older adults, but a Hawaii spine surgeon says the damage starts much earlier than most people realize. Nearly half of people aged 65 or ...

NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...

GLD Partners has secured access to Heligenics’ GigaAssay platform to launch Altagenics, a startup with ambitions to develop first-in-class medicines for muscle-wasting conditions. Altagenics will use ...

Vienna — The investigational monoclonal antibody trevogrumab was associated with lean mass preservation and greater loss of fat mass in people taking semaglutide, an interim trial data showed.